SCIENTIFIC WORK AND DISSEMINATION > PRESS FILE

December 2011

Interview with Dr. Eduardo Anitua on Onda Cero radio station

Dr Eduardo Anitua interview on the radio station Onda Cero Vitoria for the recognition delivered on 16 December, by the College of Physicians of Alava (ICOMA).

During the interview, of 8 minutes aprox, ICOMA notes that this distinction gives the doctor for his work in "innovation in the practice of medicine and dissemination of knowledge."

In addition, Anitua recognizes the work of the professional staff that is part of BTI, and speaks of research in oral implantology and regenerative therapy by the research department of BTI.

December 2011

Interview with Dr. Eduardo Anitua in Spain National Radio

Interview with the Vitorian researcher Dr. Eduardo Anitua, Scientific Director of BTI Biotechnology Institute and President of the Eduardo Anitua Foundation for biomedical research at the Spain National Radio program "En días como hoy".

Eduardo Anitua´s research to regenerate tissues.

Eduardo Anitua Doctor in medicine and surgery and Stomatology specialist talks about his research to stimulate and accelerate tissue healing and bone regeneration. "We seek a total regeneration, so that, for example, 100% muscle perform", he explains. "Cells need information and that data, come from proteins of the own patients, which is what we study." In addition, advocates of the skeptics: "Whenever there is something new people think there´s a catch, but not, we are adapting biology, for example, to orthopaedics."

December 2011

The Official Medicine Association of Alava pays tribute to Dr. Eduardo Anitua and Mikel Sanchez

The Official Medicine Association of Alava (ICOMA) has paid tribute to Dr. Eduardo Anitua and Mikel Sánchez in recognition of their innovative activity in the medicine field and the disclosure of its knowledge. The ceremony has taken place during tha annual celebration of the Association.

December 2011

El Colegio de Medicos de Alava homenajeara a los doctores Eduardo Anitua y Mikel Sanchez en su fiesta anual_version_1.01_

El Colegio Oficial de Médicos de Álava (ICOMA) realizará el próximo 16 de diciembre un homenaje a los doctores vitorianos Eduardo Anitua y Mikel Sánchez por su innovación en el ejercicio de la medicina y la difusión del conocimiento. Este acto tendrá lugar durante la celebración de la fiesta anual que celebra el Colegio, en la que se reconoce a casi un centenar de médicos de la provincia.

El Dr. Anitua es fundador y director científico de BTI Biotechnology Institute, empresa de biomedicina y biotecnología de Vitoria-Gasteiz. Así mismo, es presidente de la Fundación Eduardo Anitua para la investigación en medicina regenerativa. El Dr. Mikel Sánchez es el jefe de la unidad de Cirugía Artroscópica de la clínica USP La Esperanza de Vitoria-Gasteiz.

Reconocimiento al Médico Solidario
El Colegio de Médicos de Álava también reconocerá la labor del Dr. Jesús Mª García Calleja otorgándole el premio al “Médico solidario” por su dedicación sanitaria en países menos favorecidos y en conflicto. Este médico alavés trabaja actualmente en el departamento de VIH de la Organización Mundial de la Salud (OMS), con la que ha recorrido países como Camerún, Liberia o Guinea Ecuatorial. Su labor en Médicos sin Fronteras le ha llevado además a prestar asistencia de urgencia a refugiados en Afganistan, Yemen, Sudan, Honduras y Zambia. El Dr. García Calleja continúa colegiado en Álava.

La fiesta del ICOMA tendrá lugar el próximo 16 de diciembre a partir de las 19.30h en el Museo Artium de Vitoria-Gasteiz.

December 2011

Interview with Dr Eduardo Anitua in Intereconomia Radio

Interview the Vitorian Eduardo Anitua, doctor in medicine and surgery, and dentistry specialist and researcher. Scientific Director of BTI Biotechnology Institute and President of the Eduardo Anitua Foundation for biomedical research, on the program "Capital, la bolsa y la vida" on the Spanish Intereconomia radio station.

December 2011

Round table CIC Network 10 Science Technology and Innovation

Exciting discussion about what is understood by science, technology and innovation. Manuel Martín Lomas, Eduardo Anitua, Nuria López de Gereñu and Javier Ormazabal participate and Jose M Mato moderates taking place at BTI. The definition of science, technology and innovation is not unique and may change depending the training, profession, institution or company of the person who defines. The objective of this roundtable is to examine what we mean by science, technology and innovation, from different points of views. So Manuel Martín Lomas, CSIC research professor and scientific director of CIC biomaGUNE, Eduardo Anitua, CEO of BTI, Javier Ormazábal, President and CEO of Grupo Ormazabal, and Nuria López de Gereñu, general secretary of CONFEBASK where invited to participate.

October 2011

The Basque Government awards Dr. Eduardo Anitua with Lan Onari prize

The Basque Government awards Dr. Eduardo Anitua with “Lan Onari” prize.

Lan Onari acknowledges the merits of Basques who have achieved extraordinary distinction through their dedication, perseverance and initiative in the course of their professional activities.

In this respect, this award recognizes the intense research activity carried out by Dr. Eduardo Anitua to improve the health of the society as well as the continuous effort made to turn the Basque Country into a worldwide reference in regenerative medicine.

The Basquee President handed over the award on October 25 together with "The Gernika Cross" and "Lagun Onari" Awards.

September 2011

The Journal DIARIO MEDICO publishes an article on PRGF® Endoret® technology.

September 16, 2011, the prestigious journal "DIARIO MÉDICO" published an article about the work done by Dr. Eduardo Anitua and his research team at BTI Biotechnology Institute in the field of regenerative medicine, more specifically on Plasma Rich in Growth Factors (PRGF®-Endoret®).

This technique makes it possible to utilize the body’s own resources to achieve excellent results in a large number of conditions through tissue regeneration, without side effects and reducing considerably the recovery time of fractures, muscle and tendon injuries, and surgical interventions.

September 2011

BTI Biotechnology Institute opens its doors to media

Yesterday, September 14, BTI Biotechnology threw its doors open to the media in order to explain the various areas of biomedicine in which it works, as well as to show off its facilities which, in the area of regenerative medicine and oral implantology, are among the most cutting-edge in Spain. The event aroused considerable interest, and BTI was happy to welcome representatives from a dozen media organizations, including El País, EFE, Diario Médico, and Radio Nacional. Juan Carlos Flores, Director of Strategy and Development at BTI, was tasked with introducing the company, its origins, its development, and how it has become one of Europe’s most respected companies in the oral implantology sector, as well as a world leader in the science of tissue regeneration through the use of autologous plasma rich in growth factors (PRGF®-Endoret®). Afterwards, the journalists were invited to inspect BTI’s facilities at first hand, boasting technologically ground-breaking equipment. The journalists were specially interested in seeing not only the facilities in the R&D area, but also the operating rooms, the most modern and best-equipped in Spain, which Dr. Eduardo Anitua himself took time to show and explain to the visitors. Next it was the turn of Gorka Orive, Head of the Regenerative Medicine Laboratory at BTI, who proceeded to give the assembled media a brief introduction to the topic of plasma rich in growth factors, early research efforts, the company’s investment in R&D&I, the many laboratory and clinical studies, as well as the different therapeutic applications for PRGF®-Endoret®, among others. Finally, Dr. Anitua drew attention to the latest advances and the vast present and future therapeutic possibilities that have been opened up thanks to this innovative technique, after which he fielded questions from the members of the media.

November 2010

Innovation Seal 2010.

BTI has been awarded with the second prize of “Innovation Seal 2010” awards at “best R+D infrastructure” category. This is the recognition to the several developments done at business network. The “Innovation Seal 2010” Awards are organised by the Association of Science and Technology Parks of Spain (APTE), with the support of the Spanish Ministry of Science and Innovation.

October 2010

The World Anti Doping Agency (WADA) has withdrawn from the 2011 list of prohibited substances and methods the intramuscular treatment which includes PRGF

The World Anti-Doping Agency (WADA) has withdrawn from the 2011 list of prohibited substances and methods the intramuscular treatment known as PRP, which includes PRGF, the treatment with autologous growth factors (from the patient himself), developed by the Spanish doctors Eduardo Anitua and Mikel Sánchez. This procedure, which greatly accelerates tissue regeneration times to allow an earlier return to sports, had been included by WADA in the 2010 list of prohibited substances and methods for use in muscular injuries, although it was allowed both for tendon and ligament injuries. Thanks to the mediation of the Spanish Olympic Committee (COE), the innovative treatment of the Spanish doctors Eduardo Anitua and Mikel Sánchez has been allowed again by the World Anti-Doping Agency. Over the period of one year, the Spanish doctors have been providing scientific evidence to demonstrate that their innovative injury treatment does not result in any doping. The evidence, in form of extensive documentation that was first submitted to the Spanish Anti-Doping Agency, then to the Medical Commission of the International Olympic Committee and finally to the World Anti-Doping Agency, convinced the members of the WADA that the pioneering treatment of the two Spanish doctors is not performance enhancing.

June 2010

Eduardo Anitua and Mikel Sánchez collaborate with the International Olympic Committee to establish the guidelines for Plasma Rich in Platelets used in Sport.

The meeting, which was attended by a large group of experts in different medical fields such as orthopaedic or sports medicine, aims to reach an agreement on guidelines for the application of plasma growth factors and their use in the treatment of sports injuries. Among other conclusions, all the meeting attendees recognized BTI and Eduardo Anitua as the pioneer in the development of this 100% autologous technique and Mikel Sánchez for its implementation in orthopaedic surgery and sports medicine, which has been proved to be the most effective in the treatment of tendon, ligament, intra-articular, …injuries.

January 2010

BTI published an article of high scientific impact in International Journal of Periodontics and Restorative Dentistry

The aim of this study was to evaluate the influence of the length, diameter, and geometry of Biotechnology Institute dental implants on stress distribution in bone. Three-dimensional finite element models of osseointegrated titanium dental implants were created for this study. A force of 150 N was applied at an angle of 30 degrees. The four implant systems used were: Tiny, Interna Universal, Interna Plus, and Interna Wide, and presented the following platforms: 3.5, 4.1, 4.1 (with a 4.8-mm neck), and 5.5 mm, respectively. Implant lengths of 8.5, 10.0, 11.5, 13.0, and 15.0 mm and diameters of 2.5, 3.3, 3.75, 4.0, 4.5, and 5.0 mm were evaluated. Results showed that the effect of implant diameter on stress distribution in bone was more significant than the effect of the implant’s length or its geometry. The maximum stress was located around the neck of the implant and the majority of the stress, independent of the parameter being studied, was distributed in the bone adjacent to the first six threads of the implant. Based on these finite element studies, the use of wider implants may be better to dissipate the acting forces and thus reduce the stress in the bone surrounding the implant. Additionally, the use of shorter and wider implants might be a reasonable alternative in sites limited by the height of the residual ridge.

December 2009

Eduardo Anitua Foundation begins its activity with the First International Symposium on Translational Medicine

Eduardo Anitua Foundation began its activity. It is a non profit organization with the purpose of promoting, boosting and developing the scientific research and its dissemination.. The foundation will research lines with a strong social character and promote To boost Health Care Activities so that disadvantaged groups can be treated with the latest advances in biomedicine. Among others, it will promote biomedical research applied to regenerative medicine and tissue engineering, where, through the development he has achieved with plasma rich in growth factors after nearly 15 years of research, occupies a pioneering and very relevant international position in this field. The other pillars on which the activity of the Eduardo Anitua Foundation is settled are research, dissemination of scientific knowledge and specialized training in the bioscience field. The presentation of the Eduardo Anitua Foundation coincided with the introduction of its first activities of science dissemination and pioneering statewide, the First International Symposium on Translational Regenerative Medicine that took place last October 31 in Vitoria. The event, which comes with a biennial periodicity, was opened by Dr. Rafael Bengoa, Minister of Health and Consumption of the Basque Government, and counted with speakers of the highest international level who shared their research and clinical experiences in the fields of regenerative medicine, tissue engineering and stem cells.